Xiaobin Zeng

8PUBLICATIONS
10CO-AUTHORS
GlycoconjugatesMedical bacteriologyMolecular targetsTraditional Chinese medicine and treatmentsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 11, 2023
Formal synthesis of cyclotheonellazole A.

Bohua Long, Liuyang Pu, Zhanyan Liu

|Feb 23, 2023
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular <i>Mycobacterium Tuberculosis</i> Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation.

Haoqiang Wan, Yi Cai, Lingyun Xiao

|Sep 01, 2022
Isoginkgetin, a potential CDK6 inhibitor, suppresses <i>SLC2A1/GLUT1</i> enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma.

Jie Yao, Shuming Tang, Chenyan Shi

|May 13, 2022
Novel caffeoylquinic acid derivatives from <i>Lonicera japonica</i> Thunb. flower buds exert pronounced anti-HBV activities.

Lanlan Ge, Haoqiang Wan, Shuming Tang

|May 09, 2022
Highly stereoselective gram scale synthesis of all the four diastereoisomers of Boc-protected 4-methylproline carboxylates.

Kehuan Sun, Cheng Tao, Bohua Long

|Mar 03, 2021
Identification of Phelligridin-Based Compounds as Novel Human CD73 Inhibitors.

Sifan Lyu, Yunshuo Zhao, Xiao Zeng

Pageof 2

Frequent Collaborators

3 joint publications

Bohua Long

1 joint publications

Jiangfeng Du

1 joint publications

Zhengzhi Wu

1 joint publications

Hsiang-I Tsai